2m 2m 2m 2m 2m 2m 2m
Valion Bio (VBIO)
NASDAQ
$2.25-$0.01 (-0.66%)
Price as of Sep 11, 2026 7:57 PM EDT- $2.0MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
Valion Bio (VBIO)
$2.25-$0.01 (-0.66%)
VBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.26 | ||
Change | +$0.06 (+2.73%) | ||
Open | $2.19 | ||
High | $2.39 | ||
Low | $2.17 | ||
Previous Close | $2.20 | ||
Volume | 161,111 | ||
30-Day Average Volume | 1,054,369 | ||
1-Week Change | -18.41% | ||
1-Month Change | -70.84% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 887,589 | ||
Total Assets | $32.5M | ||
Market Cap | $2.0M | ||
Enterprise Value | $7.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$7.1M | ||
Free Cash Flow | -$5.3M | ||
EBIT | -$6.4M | ||
EBITDA | -$6.1M | ||
Net Working Capital | $336,000.00 | ||
EPS | -$54.25 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/31/2026 | ||
Earnings & Revenue